Clinical Trial Update: Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating strategies to improve endothelial and fibrinolytic dysfunction in obesity within metabolic syndrome; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Vanderbilt University | Conditions: Metabolic Syndrome X | Phase 4 | Status: TERMINATED | Results posted: 2017-05-01